The Alzheimer variant of Lewy body disease: A pathologically confirmed case-control study [PDF]
The objective of the study was to identify clinical features that distinguish patients with dementia with Lewy bodies (DLB), who were classified as Alzheimer's disease ( AD) patients, from patients with AD.
Busch, R. +7 more
core +3 more sources
Disinhibition of hippocampal CA3 neurons induced by suppression of an adenosine A1 receptor-mediated inhibitory tonus: Pre- and postsynaptic components [PDF]
Intracellular recordings were performed on hippocampal CA3 neuronsin vitro to investigate the inhibitory tonus generated by endogenously produced adenosine in this brain region.
Alzheimer +60 more
core +1 more source
Intervención psicológica familiar en la enfermedad de alzheimer
La demencia es un síndrome adquirido, de naturaleza orgánica caracterizado por un deterioro permanente de la memoria y de otras funciones intelectuales, y frecuentemente acompañado de otros trastornos psiquiátricos, que ocurren sin alteración del nivel ...
Francisco Javier Balea Fernández +1 more
doaj +1 more source
Mapas de color: Un proyecto de intervención artística con personas con alzheimer y otras demencias.
Mapas de color, un mundo de memorias, es un proyecto de Arte y Salud (AR.S) financiado por la beca PIRTU de la Junta de Castilla y León y Fondo Social Europeo (ORDEN EDU/1204/2010, de 26 de Agosto), implementado en el Centro de Referencia Estatal de ...
Lorena López-Méndez
doaj +1 more source
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic neurodegenerative disease that causes an amnestic cognitive impairment in its prototypical presentation and non-amnestic cognitive impairment in its less common variants.
David S. Knopman +7 more
openaire +2 more sources
Biomarkers in alzheimer’s dementia: health system and ageism
The aging of the population in Spain is an issue that not only concerns the health of the population and Health, but also has important repercussions on the economy, family structure, sustainability of the pension system, etc.
Francisco Javier Balea Fernández +1 more
doaj +1 more source
Alzheimer and vascular brain diseases: Focal and diffuse subforms. [PDF]
Alois Alzheimer is best known for his description of the pre-senile neurodegenerative disease named after him. However, his previous interest in vascular brain diseases, underlying cognitive and behavioral changes, was very strong. Besides describing the
Engelhardt, Eliasz, Grinberg, Lea T
core +2 more sources
Alois Alzheimer and vascular brain disease: Arteriosclerotic atrophy of the brain. [PDF]
Alois Alzheimer is best known for his description of neurofibrillary changes in brain neurons of a demented patient, identifying a novel disease, soon named after him by Kraepelin.
Engelhardt, Eliasz, Grinberg, Lea T
core +2 more sources
A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. [PDF]
Clues to Alzheimer disease (AD) pathogenesis come from a variety of different sources including studies of clinical and neuropathological features, biomarkers, genomics and animal and cellular models. An important role for amyloid precursor protein (APP)
Cheng, Soan +11 more
core +4 more sources
Background: Ongoing participant recruitment challenges in dementia research highlight the need to understand public perspectives on research participation.
Lukas A. Duffner +5 more
doaj +1 more source

